Fertility preservation in 2026: current landscape in Europe and the United States for children and adolescents undergoing hematopoietic stem cell transplantation—recommendations on behalf of the Westhafen Intercontinental Group - Takeaways - MDSpire

Fertility preservation in 2026: current landscape in Europe and the United States for children and adolescents undergoing hematopoietic stem cell transplantation—recommendations on behalf of the Westhafen Intercontinental Group

  • By

  • Andrea Jarisch

  • Seth J. Rotz

  • Alessandro Cattoni

  • Blandine Courbiere

  • Scott D. Lundy

  • Kyle E. Orwig

  • Catherine Poirot

  • Jean-Hugues Dalle

  • Rachel Phelan

  • Tamara Diesch-Furlanetto

  • May 12, 2026

  • 0 min

Share

  • 1

    Hematopoietic stem cell transplantation (HSCT) can significantly impact future fertility in pediatric patients, affecting their quality of life.

  • 2

    Fertility preservation options, such as ovarian and testicular tissue cryopreservation, are increasingly available for young patients undergoing HSCT.

  • 3

    Comprehensive counseling about fertility risks and preservation options is essential and often legally required before HSCT.

  • 4

    Counseling should include risk assessments, available techniques, and tailored discussions based on the patient's individual circumstances.

  • 5

    A multidisciplinary team approach is recommended for delivering effective fertility preservation counseling and support to pediatric HSCT patients.

Original Source(s)

Fertility preservation in 2026: current landscape in Europe and the United States for children and adolescents undergoing hematopoietic stem cell transplantation—recommendations on behalf of the Westhafen Intercontinental Group

  • by Andrea Jarisch, Seth J. Rotz, Alessandro Cattoni, Blandine Courbiere, Scott D. Lundy, Kyle E. Orwig, Catherine Poirot, Jean-Hugues Dalle, Rachel Phelan, Tamara Diesch-Furlanetto

  • May 12, 2026

Related Content

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors